Clinical trials for gene therapy in lysosomal diseases with CNS involvement

C Sevin, K Deiva - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
There are over 70 known lysosomal storage disorders (LSDs), most caused by mutations in
genes encoding lysosomal hydrolases. Central nervous system involvement is a hallmark of …

[HTML][HTML] From Lysosomal Storage Disorders to Parkinson's Disease–Challenges and Opportunities

R Mächtel, FA Boros, JP Dobert, P Arnold… - Journal of Molecular …, 2023 - Elsevier
Lysosomes are specialized organelles with an acidic pH that act as recycling hubs for
intracellular and extracellular components. They harbour numerous different hydrolytic …

Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking

I Stojkovska, WY Wani, F Zunke, NR Belur… - Neuron, 2022 - cell.com
Neurodegenerative disorders are characterized by a collapse in proteostasis, as shown by
the accumulation of insoluble protein aggregates in the brain. Proteostasis involves a …

Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration

S Mahali, R Martinez, M King, A Verbeck… - Translational …, 2022 - nature.com
Impaired proteostasis is associated with normal aging and is accelerated in
neurodegeneration. This impairment may lead to the accumulation of protein, which can be …

Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease

L Francelle, JR Mazzulli - Brain research, 2022 - Elsevier
Lysosomal storage diseases (LSDs) are rare genetic disorders caused by a disruption in
cellular clearance, resulting in pathological storage of undegraded lysosomal substrates …

Human iPSC-based models for the development of therapeutics targeting neurodegenerative lysosomal storage diseases

M Luciani, A Gritti, V Meneghini - Frontiers in Molecular Biosciences, 2020 - frontiersin.org
Lysosomal storage diseases (LSDs) are a group of rare genetic conditions. The absence or
deficiency of lysosomal proteins leads to excessive storage of undigested materials and …

Childhood dementia: A collective clinical approach to advance therapeutic development and care

JV Djafar, AM Johnson, KL Elvidge, MA Farrar - Pediatric Neurology, 2023 - Elsevier
Childhood dementias are a group of over 100 rare and ultra-rare pediatric conditions that
are clinically characterized by chronic global neurocognitive decline. This decline is …

[HTML][HTML] Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue

I Stojkovska, JR Mazzulli - STAR protocols, 2021 - Elsevier
The accumulation of proteins into insoluble aggregates is a common feature of several
neurodegenerative diseases. Aggregated α-synuclein is a major component of Lewy bodies …

Neuronal and astrocytic differentiation from Sanfilippo C syndrome iPSCs for disease modeling and drug development

N Benetó, M Cozar, L Castilla-Vallmanya… - Journal of Clinical …, 2020 - mdpi.com
Sanfilippo syndrome type C (mucopolysaccharidosis IIIC) is an early-onset
neurodegenerative lysosomal storage disorder, which is currently untreatable. The vast …

Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE

J Du, F Liu, X Liu, D Zhao, D Wang, H Sun… - Journal of Translational …, 2024 - Springer
Inherited deficiency of thymidine phosphorylase (TP), encoded by TYMP, leads to a rare
disease with multiple mitochondrial DNA (mtDNA) abnormalities, mitochondrial …